Vinorelbine and Oxaliplatin (Vinox) With or Without Trastuzumab (HerceptinÂ®) in Advanced Breast Carcinoma
Study Objective :

To assess the efficacy and the safety of the combination of Oxaliplatin, and Vinorelbine with or without Trastuzumab as a salvage regimen in patients with Metastatic Breast Cancer
Breast Neoplasms
DRUG: Oxaliplatin|DRUG: vinorelbine
overall response rate, During the Study Conduct|time to progression (TTP)., during the study conduct
survival, During the study conduct|tolerance, During the study conduct|toxicity., During the study conduct
Study Objective :

To assess the efficacy and the safety of the combination of Oxaliplatin, and Vinorelbine with or without Trastuzumab as a salvage regimen in patients with Metastatic Breast Cancer